Archive
Buds & Duds: iAnthus Capital rallies after closing its acquisition of MPX Bioceutical
Cronos Group declined following a downgrade to Hold by GMP Securities while Aphria fell after its board rejected Green Growth's hostile takeover bid
Company
Cronos Group Inc
NASDAQ:CRON
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach®, PEACE NATURALS®, and Lord Jones®.
114 stories · page 3 of 6
Aphria shares pop after short-seller Andrew Left moves to sell stake
Aphria shares are trading higher before the opening bell after short-seller Andrew Left moved to take profits in the cannabis company
Short-seller Andrew Left of Citron Research sounds off: take profits in Aphria, short Cronos Group
Citron Research said 'Canadian weed' has 'run too far' and would be moving into US names
Archive
Buds & Duds: Shares of Weekend Unlimited surge after POT ticker win
Shares of Weekend Unlimited jumped more than 134% on Friday, after it announced it won the lottery for the POT stock ticker
Buds & Duds: High Times for HEXO Corp and Cronos Group
HEXO Corp won approval this week for a listing on the NYSE American Exchange
Archive
Buds & Duds: Canopy Growth still picking up steam thanks to New York hemp license
Cannabis stocks in the US and Canada are struggling in early trade
Buds & Duds: Lexaria Bioscience shares jump on partnership deal; Tilray sinks as stock lock-up period ends
The bulk of US and Canadian cannabis companies lagged on Tuesday, after attorney general nominee William Barr said that the current system around marijuana laws is 'untenable' and he supports prohibiting marijuana across the US
Cannabis companies heartened as New York weighs legalization and US farm bill nears passage
Crop Infrastructure and Redfund Capital are companies encouraged by political developments supporting the medical and recreational marijuana industry
Canopy Growth remains the superior bet when playing cannabis stocks, says Jim Cramer
The benefits Canopy Growth holds over Cronos are scale and a $4 billion investment by Constellation Brands
Buds & Duds: Aphria and Cronos riding high while Canopy Growth and Tilray shares slip
Aphria shares are back on the rise after taking a hit from a short-seller report
Altria makes C$2.4B investment in Canadian cannabis company Cronos Group
The tobacco giant Altria is looking to widen its business beyond tobacco while Cronos is looking for a strategic partner to provide capital
Buds & Duds: Dual-listed cannabis stocks surge in Canada, but sink in the US ahead of farm bill decision
The farm bill may legalize hemp and hemp-derived CBD in the US on the federal level
Buds & Duds: Cannabis stocks drop on the back of broader market weakness
Shares of Cronos perked up again after it was reported that the maker of Marlboro cigarettes is in initial discussions to either take a stake in or possibly acquire the company
Investments and investor services
EARLY MOVERS: Restoration Hardware shares shine as it raises revenue guidance: Toll Brothers slide
Also in the frame before the New York bell are Smartsheet Inc, Toll Brothers, Dollar General Corp, Aphria Inc and Cronos Group Inc
Altria in investment talks with Canadian cannabis company Cronos
The legalization of marijuana by Canada is prompting renewed interest in investment in the country’s cannabis companies
Buds & Duds: Canopy Growth, Tilray, Aurora Cannabis, MedMen and other notable names take a hit
Cannabis-focused life-science company CV Sciences was one of the few gainers on the North American Marijuana Index
Buds & Duds: Cannabis stocks have a mixed Thursday after broader markets slip
Cannabis stocks saw a host of red and green across the board on Thursday
Buds & Duds: cannabis stocks end on a low note, despite news from Congress
Cannabis stocks dropped Tuesday, despite news that Congress was close to finishing a farm bill, which includes provisions to legalize hemp
Buds & Duds: Rough start to the week for cannabis stocks as Canopy Growth and Aurora Cannabis shares dip
GW Pharmaceuticals was a top gainer on the North American Marijuana Index following positive data from its trial of Epidiolex, a treatment for a form of childhood epilepsy
Buds & Duds: Industrial Properties, ICC international Cannabis the only gainers in cannabis space
Innovative Industrial Properties, which leases medical cannabis facilities, was one of the only gainers on the North American Marijuana Index